Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1995
11/23/1995WO1995031552A2 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE
11/23/1995WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031208A1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/23/1995WO1995031206A1 P75 tnf receptor promoters
11/23/1995WO1995031107A1 Immunotherapeutic strategies for the treatment of cancer
11/23/1995WO1995031105A1 A method of inducing an immune response using vaccinia virus recombinants
11/23/1995CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190161A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2188421A1 Alphavirus expression vector
11/23/1995CA2188157A1 Nucleic acid sequences controlling lung cell-specific gene expression
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0682712A1 Human interferon expression vectors for treating aids
11/22/1995EP0682708A1 Antiviral composition of viral protein trans-dominant variants
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030762A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995WO1995030761A2 Methods of in vivo gene delivery
11/16/1995WO1995030746A1 Antisense inhibition of hepatitis c virus
11/16/1995WO1995030693A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995WO1995030433A1 A novel brain endothelial cell protein and methods for its use
11/16/1995CA2190027A1 A novel brain endothelial cell protein and methods for its use
11/16/1995CA2189582A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995CA2189452A1 Methods of in vivo gene delivery
11/16/1995CA2188450A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682112A1 Method for archiving expression, or to improve the level of expression of a gene
11/15/1995EP0682111A1 Chimeric or transgenic animal and process for screening pharmaceutical products
11/15/1995EP0681483A1 Compositions and methods for delivery of genetic material
11/15/1995EP0681482A1 Localization of therapeutic agents
11/15/1995EP0681477A1 Genetic modification of neural stem cells
11/14/1995US5466786 2'modified nucleoside and nucleotide compounds
11/14/1995US5466676 Satellite cell proliferation in adult skeletal muscle
11/14/1995US5466596 Genetic engineering
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030013A1 Human-origin prostacyclin synthase
11/09/1995WO1995030007A1 Thymidine kinase mutants
11/09/1995WO1995030002A2 Enhancing the sensitivity of tumor cells to therapies
11/09/1995WO1995030000A1 Dna sequences
11/09/1995WO1995029704A1 Cell lines obtained by in vivo migration and by fusion with autoimmune cells
11/09/1995WO1995029703A1 Introduction of hiv-protective genes into cells by particle-mediated gene transfer
11/09/1995WO1995028166A3 Method for implanting encapsulated cells in a host
11/09/1995DE4441327C1 Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung Embryonic heart muscle cells, their preparation and their use
11/09/1995CA2189543A1 Thymidine kinase mutants
11/09/1995CA2189438A1 Dna sequences
11/09/1995CA2189032A1 Enhancing the sensitivity of tumor cells to therapies
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680334A1 Morphogen treatment of gastrointestinal ulcers
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0680315A1 Method for preparing a viral aerosol
11/08/1995CN1111159A Specificity gene transfering technology of applying endothelial tissue ligand and sequential gene regulating amboceptor
11/07/1995US5464764 Method for enriching transformed murine embryonic stem cell containing modification in target DNA sequence in genome of cell
11/07/1995US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques
11/02/1995WO1995029259A1 Method and means for detecting and treating disorders in the blood coagulation cascade
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029186A1 Compositions and methods for cell transformation
11/02/1995WO1995028948A1 Compositions comprising dna damaging agents and p53
11/02/1995WO1995028907A2 Megapoietin: a novel megakaryocyte growth promoting factor
11/02/1995EP0679402A2 Biologically active substance-secreting hybrid gel
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995DE4415001A1 Treatment of eukaryotic cells with cpds. that bind lipo-polysaccharide
11/02/1995CA2188320A1 Compositions and methods for cell transformation
10/1995
10/31/1995US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028167A1 Methods of treating disease using sertoli cells and allografts or xenografts
10/26/1995WO1995028166A2 Method for implanting encapsulated cells in a host
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2187818A1 Gene delivery fusion proteins
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2187335A1 Method for implanting encapsulated cells in a host
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995CA2147810A1 Biologically active substance-secreting hybrid gel
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678101A1 Growth differentiation factor-9
10/24/1995US5460959 Transduced fibroblasts
10/24/1995US5460831 Targeted transfection nanoparticles
10/24/1995US5460830 Biochemically active agents for chemical catalysis and cell receptor activation
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
1 ... 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 ... 870